Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19
frontiersin.orgMetagenomic next-generation sequencing (mNGS) has a significant value in the diagnosis of Chlamydia psittaci infection. Timely treatment of omadacycline can improve prognosis and provide a promising new option for the treatment of severe Chlamydia psittaci pneumonia with ARDS.
Common symptoms included fever, dyspnea, and cough. All patients developed ARDS, accompanied by septic shock (43.7%) and pulmonary embolism (43.7%).
Laboratory data showed normal leucocytes, increased creatine kinase isoenzyme, and decreased albumin with liver dysfunction in most patients. All patients had increased neutrophils, C-reactive protein, procalcitonin, and D-dimer with decreased lymphocytes. Airspace consolidation, ground glass opacity, and pleural effusion were found on chest CT.
mNGS results were obtained in 24–48 h to identify the diagnosis of Chlamydia psittacosis.
All patients received mechanical ventilation with omadacycline treatment.
Fourteen patients experienced complete recovery, while the other two patients died from multidrug-resistant bacterial infection and renal failure.